Phase II evaluation of mitozolomide in ovarian cancer
Open Access
- 1 January 1988
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (1) , 113-114
- https://doi.org/10.1038/bjc.1988.21
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Mitozolomide activity on human cancer cells in vitroBritish Journal of Cancer, 1986
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- PHASE-I CLINICAL-TRIAL OF MITOZOLOMIDE1985
- ANTITUMOR IMIDAZOTETRAZINES .6. EXPERIMENTAL ANTITUMOR-ACTIVITY AGAINST MURINE TUMOR-MODEL SYSTEMS OF 8-CARBAMOYL-3-(2-CHLOROETHYL)IMIDAZO[5,1-D]-1,2,3,5-TETRAZIN-4(3H)-ONE(MITOZOLOMIDE), A NOVEL BROAD-SPECTRUM AGENT1985
- Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agentJournal of Medicinal Chemistry, 1984